If you or a loved one suffered serious liver complications after taking Ocaliva (obeticholic acid), you may be entitled to financial compensation. Reports have linked Ocaliva to severe liver injury, liver failure, hospitalization, and death in certain patients.
Phillips Law is investigating claims on behalf of individuals who experienced worsening liver function after using this medication. Drug manufacturers have a duty to warn patients and doctors about serious risks. When they fail to do so, they can be held legally responsible.
Ocaliva (obeticholic acid) is a prescription medication approved to treat primary biliary cholangitis (PBC), a chronic liver disease that damages bile ducts. The drug is manufactured by Intercept Pharmaceuticals and was approved under accelerated FDA approval.
Although intended to slow liver disease progression, post-marketing reports and FDA safety communications raised concerns that Ocaliva may increase the risk of serious liver injury, especially in patients with advanced cirrhosis.
Patients taking Ocaliva have reported:
The FDA issued safety warnings regarding improper dosing and increased risk in patients with moderate to severe liver impairment. In some cases, patients allegedly received incorrect dosing schedules, contributing to liver decompensation.
Ocaliva lawsuits generally allege that:
Plaintiffs claim that proper warnings or stronger safety measures could have prevented serious injuries.
You may qualify if:
Medical records, prescription history, and documented liver injury are key components of evaluating a claim.
An Ocaliva lawsuit may seek compensation for:
Every case is different, and potential compensation depends on the severity of the injury and long-term impact.
The FDA has issued multiple safety communications related to Ocaliva dosing and liver injury risk. Regulatory scrutiny has focused on whether patients with advanced liver disease were adequately protected.
Accelerated approval programs require continued safety monitoring. When post-approval evidence reveals serious harm, legal accountability may follow.
Dangerous drug litigation requires experience, medical understanding, and resources. Phillips Law investigates pharmaceutical injury cases nationwide and works with medical experts to build strong claims for clients harmed by unsafe medications.
We understand how devastating liver failure and transplant complications can be. Our team is committed to pursuing justice for individuals and families affected by pharmaceutical negligence.
If you believe Ocaliva caused serious liver complications, do not wait to seek legal advice. Drug injury claims are subject to strict filing deadlines.
Contact Phillips Law today to discuss your potential Ocaliva lawsuit and learn whether you may be eligible to pursue compensation.